Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

With unfortunately no curative therapy for chronic spontaneous urticaria (CSU) available for now, the overall goal is to ...

KEY TAKEAWAYS Incyte led S&P 500 decliners Tuesday afternoon after the pharmaceutical firm said it will stop developing one ...

Patients with chronic hives (when hives last or continue ... Acupuncture: Some studies looking at the efficacy of acupuncture in treating hives have yielded positive results.

While her research had quickly led her to believe that the itching and welts were hives, "I wasn't able to ... ethnic disparities in healthcare, and chronic conditions. Prior to joining PS ...

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...

In November 2021, however, she came up against a case nearly impossible to solve. It all started when Elisha woke up with an ...

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

1 While second-generation H1-antihistamines are standard therapy for both acute and chronic urticaria, some patients need additional treatment to find relief. A new study investigates whether ...